1. Executive Summary
1.1. Global Healthcare Reimbursement Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2022
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. Covid-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Healthcare Reimbursement Market Outlook, 2018 - 2030
3.1. Global Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
3.1.1. Key Highlights
3.1.1.1. Fully Paid
3.1.1.2. Underpaid
3.2. Global Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
3.2.1. Key Highlights
3.2.1.1. Private Payers
3.2.1.2. Public Payers
3.3. Global Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
3.3.1. Key Highlights
3.3.1.1. Physician Office
3.3.1.2. Hospitals
3.3.1.3. Diagnostic Laboratories
3.3.1.4. Others
3.4. Global Healthcare Reimbursement Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Healthcare Reimbursement Market Outlook, 2018 - 2030
4.1. North America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
4.1.1. Key Highlights
4.1.1.1. Fully Paid
4.1.1.2. Underpaid
4.2. North America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
4.2.1. Key Highlights
4.2.1.1. Private Payers
4.2.1.2. Public Payers
4.3. North America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
4.3.1. Key Highlights
4.3.1.1. Physician Office
4.3.1.2. Hospitals
4.3.1.3. Diagnostic Laboratories
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
4.4.1. Key Highlights
4.4.1.1. U.S. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
4.4.1.2. U.S. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
4.4.1.3. U.S. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
4.4.1.4. U.S. Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
4.4.1.5. Canada Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
4.4.1.6. Canada Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
4.4.1.7. Canada Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
4.4.1.8. Canada Healthcare Reimbursement Market, by End Use, Value (US$ Bn), 2018 - 2030
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Healthcare Reimbursement Market Outlook, 2018 - 2030
5.1. Europe Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
5.1.1. Key Highlights
5.1.1.1. Fully Paid
5.1.1.2. Underpaid
5.2. Europe Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
5.2.1. Key Highlights
5.2.1.1. Private Payers
5.2.1.2. Public Payers
5.3. Europe Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
5.3.1. Key Highlights
5.3.1.1. Physician Office
5.3.1.2. Hospitals
5.3.1.3. Diagnostic Laboratories
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
5.4.1. Key Highlights
5.4.1.1. Germany Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
5.4.1.2. Germany Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
5.4.1.3. Germany Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
5.4.1.4. U.K. Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
5.4.1.5. U.K. Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
5.4.1.6. U.K. Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
5.4.1.7. France Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
5.4.1.8. France Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
5.4.1.9. France Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
5.4.1.10. Italy Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
5.4.1.11. Italy Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
5.4.1.12. Italy Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
5.4.1.13. Turkey Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
5.4.1.14. Turkey Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
5.4.1.15. Turkey Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
5.4.1.16. Russia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
5.4.1.17. Russia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
5.4.1.18. Russia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
5.4.1.19. Rest of Europe Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
5.4.1.20. Rest of Europe Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
5.4.1.21. Rest of Europe Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Healthcare Reimbursement Market Outlook, 2018 - 2030
6.1. Asia Pacific Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
6.1.1. Key Highlights
6.1.1.1. Fully Paid
6.1.1.2. Underpaid
6.2. Asia Pacific Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
6.2.1. Key Highlights
6.2.1.1. Private Payers
6.2.1.2. Public Payers
6.3. Asia Pacific Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
6.3.1. Key Highlights
6.3.1.1. Physician Office
6.3.1.2. Hospitals
6.3.1.3. Diagnostic Laboratories
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
6.4.1. Key Highlights
6.4.1.1. China Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
6.4.1.2. China Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
6.4.1.3. China Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
6.4.1.4. Japan Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
6.4.1.5. Japan Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
6.4.1.6. Japan Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
6.4.1.7. South Korea Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
6.4.1.8. South Korea Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
6.4.1.9. South Korea Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
6.4.1.10. India Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
6.4.1.11. India Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
6.4.1.12. India Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
6.4.1.13. Southeast Asia Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
6.4.1.14. Southeast Asia Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
6.4.1.15. Southeast Asia Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
6.4.1.16. Rest of Asia Pacific Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
6.4.1.17. Rest of Asia Pacific Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
6.4.1.18. Rest of Asia Pacific Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Healthcare Reimbursement Market Outlook, 2018 - 2030
7.1. Latin America Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
7.1.1. Key Highlights
7.1.1.1. Fully Paid
7.1.1.2. Underpaid
7.2. Latin America Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
7.2.1. Key Highlights
7.2.1.1. Private Payers
7.2.1.2. Public Payers
7.3. Latin America Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
7.3.1. Key Highlights
7.3.1.1. Physician Office
7.3.1.2. Hospitals
7.3.1.3. Diagnostic Laboratories
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
7.4.1. Key Highlights
7.4.1.1. Brazil Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
7.4.1.2. Brazil Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
7.4.1.3. Brazil Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
7.4.1.4. Mexico Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
7.4.1.5. Mexico Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
7.4.1.6. Mexico Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
7.4.1.7. Argentina Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
7.4.1.8. Argentina Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
7.4.1.9. Argentina Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
7.4.1.10. Rest of Latin America Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
7.4.1.11. Rest of Latin America Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
7.4.1.12. Rest of Latin America Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Healthcare Reimbursement Market Outlook, 2018 - 2030
8.1. Middle East & Africa Healthcare Reimbursement Market Outlook, by Claim, Value (US$ Bn), 2018 - 2030
8.1.1. Key Highlights
8.1.1.1. Fully Paid
8.1.1.2. Underpaid
8.2. Middle East & Africa Healthcare Reimbursement Market Outlook, by Payer, Value (US$ Bn), 2018 - 2030
8.2.1. Key Highlights
8.2.1.1. Private Payers
8.2.1.2. Public Payers
8.3. Middle East & Africa Healthcare Reimbursement Market Outlook, by Service Provider, Value (US$ Bn), 2018 - 2030
8.3.1. Key Highlights
8.3.1.1. Physician Office
8.3.1.2. Hospitals
8.3.1.3. Diagnostic Laboratories
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Healthcare Reimbursement Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
8.4.1. Key Highlights
8.4.1.1. GCC Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
8.4.1.2. GCC Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
8.4.1.3. GCC Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
8.4.1.4. South Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
8.4.1.5. South Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
8.4.1.6. South Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
8.4.1.7. Egypt Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
8.4.1.8. Egypt Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
8.4.1.9. Egypt Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
8.4.1.10. Nigeria Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
8.4.1.11. Nigeria Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
8.4.1.12. Nigeria Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
8.4.1.13. Rest of Middle East & Africa Healthcare Reimbursement Market by Claim, Value (US$ Bn), 2018 - 2030
8.4.1.14. Rest of Middle East & Africa Healthcare Reimbursement Market, by Payer, Value (US$ Bn), 2018 - 2030
8.4.1.15. Rest of Middle East & Africa Healthcare Reimbursement Market, by Service Provider, Value (US$ Bn), 2018 - 2030
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Service Provider vs Claim Heatmap
9.2. Company Market Share Analysis, 2022
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. UnitedHealth Group
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Anthem, Inc.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Cigna
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Humana Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Blue Cross Blue Shield Association
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Centene Corporation
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Molina Healthcare
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Kaiser Permanente
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. CVS Health
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Tenet Healthcare
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. HCA Healthcare
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
9.4.12. Magellan Health
9.4.12.1. Company Overview
9.4.12.2. Product Portfolio
9.4.12.3. Financial Overview
9.4.12.4. Business Strategies and Development
9.4.13. Universal American
9.4.13.1. Company Overview
9.4.13.2. Product Portfolio
9.4.13.3. Financial Overview
9.4.13.4. Business Strategies and Development
9.4.14. Gateway Health
9.4.14.1. Company Overview
9.4.14.2. Product Portfolio
9.4.14.3. Financial Overview
9.4.14.4. Business Strategies and Development
9.4.15. The Joint Commission
9.4.15.1. Company Overview
9.4.15.2. Product Portfolio
9.4.15.3. Financial Overview
9.4.15.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations